Calcium and Vitamin D Status in Heart Failure Patients in Isfahan, Iran

被引:0
作者
Mohammad Garakyaraghi
Maryam Kerdegari
Mansour Siavash
机构
[1] Isfahan University of Medical Sciences,
[2] Isfahan Cardiovascular Research Center,undefined
[3] Isfahan University of Medical Sciences,undefined
[4] Isfahan University of Medical Sciences,undefined
[5] Isfahan Endocrine & Metabolism Research Center,undefined
来源
Biological Trace Element Research | 2010年 / 135卷
关键词
Heart failure; Calcium; Hyperparathyroidism; Vitamin D; Left ventricular ejection fraction; NYHA functional class;
D O I
暂无
中图分类号
学科分类号
摘要
Both calcium and vitamin D play important roles in cardiac muscle contraction and performance. In this cross-sectional study, we evaluated the status of serum calcium, PTH and 25(OH)D3 and their correlation with left ventricular Function and NYHA Functional class in 95 heart failure patients referred to Shahid Chamran Hospital, Isfahan, Iran, by colorimetric, immunoradiometric, and Immunochemiluminescent assays, echocardiography and interview respectively. The study was performed between Oct 2007 and Feb 2008. Twenty eight women and 67 men of functional classes 1, 2, or 3 participated in the study. Mean (SD) of age of the participants was 62(11) years. Mean (SD) serum calcium and 25(OH)D3 were 2.41(0.16) mmol/L and 56.78(51.33) nmol/L, respectively. The overall prevalence of low vitamin D status was 84.2%. There was no correlation between serum calcium and 25(OH)D3 with LVEF. Interestingly, patients with hyperparathyroidism (serum PTH>65 ng/L) had lower LVEF (27% versus 32.5% p = 0.03). NYHA functional class was worse in patients with hyperparathyroidism (p = 0.08). Hypovitaminosis D is very prevalent in heart failure patients. Hyperparathyroidism in these patients may adversely affect cardiac function. Vitamin D3 might serve as an adjunctive treatment for heart failure patients.
引用
收藏
页码:67 / 73
页数:6
相关论文
共 145 条
[1]  
Bleumink GS(2004)Quantifying the heart failure epidemic: prevalence, incidence rate, lifetime risk and prognosis of heart failure The Rotterdam Study Eur Heart J 25 1614-1619
[2]  
Knetsch AM(2008)Heart failure incidence and survival (from the Atherosclerosis Risk in Communities study) Am J Cardiol 101 1016-1022
[3]  
Sturkenboom MC(2008)Early and long-term outcomes of heart failure in elderly persons, 2001–2005 Arch Intern Med 168 2481-2488
[4]  
Straus SM(1998)Hypovitaminosis D in medical inpatients N Engl J Med 338 777-783
[5]  
Hofman A(2005)Cardiac hypertrophy in vitamin D receptor knockout mice: role of the systemic and cardiac renin–angiotensin systems Am J Physiol Endocrinol Metab 288 E125-E132
[6]  
Deckers JW(2004)Vitamin D: a negative endocrine regulator of the renin–angiotensin system and blood pressure J Steroid Biochem Mol Biol 89-90 387-392
[7]  
Witteman JC(2007)Congestive heart failure is a systemic illness: a role for minerals and micronutrients Clin Med Res 5 238-243
[8]  
Stricker BH(2007)The importance of lost minerals in heart failure Cardiovasc Hematol Agents Med Chem 5 295-299
[9]  
Loehr LR(2006)Secondary hyperparathyroidism and hypovitaminosis D in African–Americans with decompensated heart failure Am J Med Sci 332 112-118
[10]  
Rosamond WD(2006)Secondary hyperparathyroidism in patients with untreated and treated congestive heart failure Am J Med Sci 331 30-34